Drug Profile
Research programme: drug bioconjugates - Catalent/Roche
Latest Information Update: 28 Feb 2020
Price :
$50
*
At a glance
- Originator Catalent Pharma Solutions; Roche
- Class Drug conjugates
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Unspecified